Bio-Rad Acquires Sequencing Technology Company GnuBIO |
Friday, April 11, 2014
GnuBIO is a privately-held life sciences company that has developed a droplet-based DNA sequencing technology.
An Integrated Approach to Clinical Genetics Research
Wednesday, April 09, 2014
OGT’s new whitepaper explores the next stage of molecular testing.
£12M for Synthetic Biology Facilities and Training
Monday, April 07, 2014
The UK Research Councils, led by the BBSRC, will award £10M to establish five centres for DNA synthesis across the UK to further develop the UK's research base in synthetic biology.
SYGNIS Reports Financial Results for a Successful Fiscal Year 2013
Wednesday, April 02, 2014
First products launched based on QualiPhi® now renamed SensiPhi® in early 2014.
Global Data Science Hub Launches at Imperial College London
Tuesday, April 01, 2014
Data Science Institute will foster the next generation of data scientists and engineers.
GSK, EMBL-EBI and Sanger Institute Launch Target Validation Initiative
Thursday, March 27, 2014
Centre for Therapeutic Target Validation will utilise genomics and big data to drive drug discovery.
Courtagen Life Sciences Announces Collaboration with Raptor Pharmaceuticals
Wednesday, March 26, 2014
Courtagen Life Sciences to provide genetic profiling of patients enrolling in the RP103-MITO-001 clinical trial.
Strand Genomics, BioHealth Partner
Tuesday, March 25, 2014
Effort designed to help revolutionize access to genomic interpretation services throughout the U.S.
Industry-Sponsored Academic Inventions Spur Increased Innovation
Monday, March 24, 2014
Analysis questions assumption that corporate support skews science toward inventions that are less useful than those funded by the government or non-profit organizations.